Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250612615553/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
11 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250611309310/en/Travere-Therapeutics-to-Present-New-FILSPARI-sparsentan-Data-at-the-15th-International-Podocyte-Conference
10 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250610121537/en/Travere-Therapeutics-Launches-Play-It-Forward-Campaign-to-Celebrate-the-FSGS-Community-on-Inaugural-Awareness-Day
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603883877/en/Travere-Therapeutics-to-Present-New-FILSPARI-sparsentan-Data-at-the-62nd-ERA-Congress
15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515638671/en/Travere-Therapeutics-Announces-FDA-Acceptance-of-sNDA-for-FILSPARI-sparsentan-in-FSGS
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512771363/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
ABOUT THIS PAGE